DLBCL: Clinical Trials

1 trial for DLBCL, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 suspended. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Suspended 1
Phase 21Suspended 1

Follow DLBCL: new trials by email Literature Review of DLBCL trials Research Report on DLBCL

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ph I/II Study of E7777 Prior to CAR-T for R/R LBCL
E7777, Fludarabine, Cyclophosphamide - DLBCL, Diffuse Large B Cell Lymphoma
Phase 1 / Phase 2SuspendedMasonic Cancer Center, University of Minnesota302021-06-092026-11-04

Narrower conditions

Lymphoma, Large B-Cell, Diffuse (1)

Broader conditions

Hemic and Lymphatic Diseases (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Lymphatic Diseases (1)  ·  Lymphoma (1)  ·  Lymphoma, B-Cell (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Lymphoproliferative Disorders (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)

Interventions

Cyclophosphamide (1)  ·  E7777 fusion protein (1)  ·  axicabtagene ciloleucel (1)  ·  fludarabine (1)  ·  tisagenlecleucel (1)

Sponsors

Masonic Cancer Center, University of Minnesota (1)

Countries

United States (1)

Top investigators

Veronika Bachanova, MD (1)

Results publications

PMID 38022532